Lupin Limited

NSE:LUPIN.NS

2,171.9 (INR) • At close September 19, 2024
Bedrijfsnaam Lupin Limited
Symbool LUPIN.NS
Munteenheid INR
Prijs 2,171.9
Beurswaarde 990,683,950,300
Dividendpercentage 0.24%
52-weken bereik 1,091.5 - 2,312
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Vinita D. Gupta
Website https://www.lupin.com

An error occurred while fetching data.

Over Lupin Limited

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health,

Vergelijkbare Aandelen

GlaxoSmithKline Pharmaceuticals Limited logo

GlaxoSmithKline Pharmaceuticals Limited

GLAXO.NS

2,698.35 INR

Ipca Laboratories Limited logo

Ipca Laboratories Limited

IPCALAB.NS

1,454.35 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

470.4 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,528.1 INR

Syngene International Limited logo

Syngene International Limited

SYNGENE.NS

902.1 INR

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,667.3 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

984.85 INR

Fortis Healthcare Limited logo

Fortis Healthcare Limited

FORTIS.NS

590.5 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

6,136.85 INR

Zydus Lifesciences Limited logo

Zydus Lifesciences Limited

ZYDUSLIFE.NS

1,054.45 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)